Endocyte Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
18,032.40
5,459.50
41,269.70
43,887.60
55,064.20
Depreciation, Depletion & Amortization
674.70
857.10
886.70
919.80
922.70
Other Funds
7,306.90
9,646.40
8,293.00
9,717.20
20,654.80
Funds from Operations
10,050.80
15,963.00
32,090.00
33,250.50
33,486.70
Changes in Working Capital
41,029.70
58,168.70
128.10
1,400.20
172.00
Net Operating Cash Flow
51,080.50
42,205.80
32,218.10
34,650.80
33,658.70
Capital Expenditures
827.80
1,501.70
341.60
713.80
82.50
Sale of Fixed Assets & Businesses
-
10.00
-
-
15.70
Purchase/Sale of Investments
70,120.30
67,068.50
1,832.30
50,832.70
28,205.10
Net Investing Cash Flow
69,292.40
68,560.20
1,490.60
50,118.90
15,367.80
Net Financing Cash Flow
644.90
103,491.30
627.00
328.50
5,621.80
Net Change in Cash
18,850.10
7,313.50
30,101.80
15,796.60
12,669.10
Free Cash Flow
51,908.30
43,707.50
32,559.70
35,364.60
33,741.10
Change in Capital Stock
644.90
103,491.30
627.00
328.50
5,621.80
Exchange Rate Effect
6.80
38.80
1.40
-
-
Other Uses
-
-
-
-
12,770.60
About Endocyte
View Profile
